Demand for PHT Corporation Patient-Driven eData Systems Grows 39%
PHT Corporation achieves strong growth as clinical trials become
more patient centric with greater need for patient-driven outcomes
BOSTON, Mass. and GENEVA, Switzerland –
January 22, 2014 – PHT Corporation achieved record growth in 2013 with a 39% increase in bookings over 2012.
More than 25 pharmaceutical and biotech
companies selected the PHT electronic clinical outcome assessment (eCOA) System to collect
critical data for 60+ trials and studies.
PHT saw strong growth in existing and new therapeutic areas and
indications, especially in respiratory, CNS, dermatology and oncology. PHT added 6 new clients through direct sales
and CRO partnerships and continues to lead as the trusted provider of
electronic systems for patient-driven outcomes.